Symposia Abstracts
NS13 - Nanomedicines for cancer therapy
| INTRODUCTION Fantozzi R. |
| NANOTECHNOLOGY FOR NANOMEDICINE: INORGANIC AND ORGANIC SYSTEM Krol S. |
| NANOPARTICLES ACCORDING TO THE ROUTE OF ADMINISTRATION Cavalli R. |
| CAMPTOTHECIN IN NANOSPONGES AS NEW THERAPEUTIC DELIVERY AGENT IN PROSTATE CANCER: IN VITRO AND IN VIVO EVALUATION Gigliotti C., Minelli R., Cavalli R., Occhipinti S., Barrera G., Pizzimenti S., Cappellano G., Giovarelli M., Dianzani U., Fantozzi R., Dianzani C. |
| PORPHYRIN LOADED NANOPARTICLES ENHANCE ANTICANCER EFFICACY OF SONODYNAMIC THERAPY Serpe L., Varchi G., Foglietta F., Balestri M., Canaparo R. |
| PLGA NANOPARTICLES FOR “INVERSE VACCINATION” IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) Cappellano G., Woldetsadik A., Shivakumar Y., Rizzi M., Carniato F., Orilieri E., Chiocchetti A., Battaglia L., Gallarate M., Cavalli R., Dianzani C., Renò F., Dianzani U. |
| NANOPARTICLES FOR BRAIN TUMOR TREATMENT: REQUIREMENTS FOR A CLINICAL PROSPECT Mauro A. |
| CONCLUSIONS Fantozzi R. |